AB
PRTK

Amalgamated Bank’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Amalgamated Bank’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,975
Closed -$24K – 3276
2022
Q1 		$24K Buy
+7,975
New +$30K ﹤0.01% 2750

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Amalgamated Bank's PRTK Position: Q2 2022 in Review

Amalgamated Bank sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 7,975 shares — an estimated $24K sold.

Amalgamated Bank first reported a position in PRTK in Q1 2022 and held it in 1 quarter. The position peaked at $24K in Q1 2022. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • Amalgamated Bank reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 7,975 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $24K.
  • Amalgamated Bank first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Paratek Pharmaceuticals, Inc. position peaked at $24K in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.